Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ALKS

Alkermes plc.

Pharmaceutical Preparations · SIC 2834CIK 1520262Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$1.48B
Net Income FY2025
$0.24B
EPS (Basic, as reported)
$1.47
Net Margin FY2025
16.4%
ROE FY2025
13.3%
Total Equity
$1.82B
Shares Out
168M
Business description

Alkermes plc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 746 → 1,476 +7.9% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue7469031,0941,1711,0391,1741,1121,6631,5581,476
Cost of revenue(132)(155)(176)(180)(178)(197)(218)(253)(245)(196)
Research & development(387)(413)(425)(513)(395)(407)(394)(271)(245)(324)
Selling, general & administrative(374)(422)(526)(599)(539)(561)(606)(690)(645)(702)
Selling & marketing——————(392)(490)(446)(480)
General & administrative——————(199)(200)(199)(222)
Total operating expenses(954)(1,051)(1,193)(1,346)(1,151)(1,203)(1,254)(1,249)(1,137)(1,222)
Operating income(209)(148)(99)(175)(112)(29)(142)414421254
Interest expense(15)(12)(15)(14)(9)(11)(13)(23)(23)(12)
Interest & investment income45914728314245
Other income (expense), net(6)5(28)(22)16(10)(25)72337
Pre-tax income(214)(143)(127)(197)(97)(39)(167)422444291
Income tax expense(6)(15)(12)0(14)(9)(9)(98)(72)(50)
Net income(208)(158)(139)(197)(111)(48)(158)356367242
EPS — basic————($0.70)($0.30)($0.97)$2.14$2.22$1.47
EPS — diluted————($0.70)($0.30)($0.97)$2.10$2.17$1.43
Shares outstanding — basic (M)————159161164166165165
Shares outstanding — diluted (M)————159161164170169169

Showing the latest 10 of 16 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.